Industry Reports

ACADIA Pharmaceuticals Inc. announced that Elena Ridloff, CFA, has been appointed to the newly created position of Senior Vice President, Investor Relations, leading investor and…
Read More...

ADC Biotechnology (ADC Bio), announces that it has secured £1.14 million in funding from investment managers, Downing LLP. The funds will bolster the company’s business drive for faster…
Read More...

AI genomics company Freenome announces its partnership with leading proteomics company Biognosys to enhance its broad-signal approach to early-cancer detection and precision oncology.…
Read More...

Q Therapeutics and REPROCELL announced the formation of MAGiQ Therapeutics, Inc., a Japanese joint venture company. MAGiQ will develop iPSC-derived, glial-restricted progenitor cells…
Read More...

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,919 million.  Advent’s…
Read More...

Phoenix Molecular Designs (PhoenixMD) announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026…
Read More...

Astellas Pharma and Kite, a Gilead Company announced that an agreement has been completed for the transfer of certain Agensys research facilities in Santa Monica, California, USA, to…
Read More...

Shire plc announces that it has entered into a definitive agreement with Servier S.A.S. to sell its Oncology business for $2.4 billion. Shire's Oncology business includes in-market…
Read More...

Boehringer Ingelheim and Eli Lilly and Company announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance on the progression of kidney…
Read More...

Amgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I. The new plant, the first of its kind in the United…
Read More...

Alexion Pharmaceuticals and Wilson Therapeutics AB (publ) announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all…
Read More...

Bristol-Myers Squibb Company and the Harvard Fibrosis Network of the Harvard Stem Cell Institute announce a research collaboration to discover and develop potential new therapies for…
Read More...

Evotec AG announced a strategic collaboration with Petra Pharma Corporation. Through the collaboration, Petra will access Evotec's INDiGO platform to accelerate the development of its…
Read More...

Promethera Biosciences SA announced that it has acquired Baliopharm AG, a Swiss biopharmaceutical company focused on the development of targeted biological therapies for immune mediated…
Read More...

Novartis announced that it has entered into an agreement and plan of merger with AveXis, Inc. to acquire the US-based Nasdaq-listed clinical stage gene therapy company for USD 218 per…
Read More...

Eidos Therapeutics announced a $64.0 million Series B financing. Proceeds from the financing will be used to advance Eidos' small molecule product candidate, AG10, into Phase 2 clinical…
Read More...

AbbVie announced global resolution of all intellectual property-related litigation with Samsung Bioepis over its proposed biosimilar adalimumab product. Under the terms of the…
Read More...

Stemline Therapeutics announced that it has initiated its rolling submission of a Biologics License Application (BLA) for SL-401 to the U.S. Food and Drug Administration (FDA). SL-401…
Read More...

Agilent Technologies Inc. and Lasergen, Inc. (Lasergen) announced that they have signed a definitive agreement for Agilent to acquire the remaining shares of Lasergen, an emerging…
Read More...

Versant Ventures announced that Roche Holdings Inc. has acquired the Inception 5 program, focused on regenerative therapies for multiple sclerosis. Financial terms are not disclosed.…
Read More...